NEW HAVEN, Conn.--(BUSINESS WIRE)--Cogstate Ltd (ASX:CGS), leaders in the measurement of cognition in clinical trials, is pleased to announce that their iPad-based computerized cognitive assessment ...

MELBOURNE, Australia--(BUSINESS WIRE)--Cogstate Ltd (ASX:CGS), a cognitive science and medical technology company, today announced the latest version of its remote cognitive assessment solution for ...

Science-driven collaboration ameliorates neurological assessments and endpoint data quality, enhances the rater and patient experience, and integrates Medidata App innovations with Cogstate ...

Biopharma sponsors and CROs now have access to a modern eCOA solution that seamlessly integrates a configurable, no-code platform with validated cognitive assessments and deep clinical expertise ...

An announcement from Cogstate Ltd ( ($AU:CGS) ) is now available. Cogstate Ltd, an ASX-listed cognitive assessment and healthcare technology ...

Melbourne, VIC, Australia; New Haven, CT, USA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Cogstate (COGZF), a leading neuroscience technology company, today announced the ...

MELBOURNE, Australia, Oct. 26, 2020 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Cogstate, Ltd. (Headquarters: Melbourne ...

April 15, 2008 (Chicago, Illinois) — Although women treated for breast cancer frequently report cognitive problems during chemotherapy, 2 new studies suggest that the chemotherapy itself may not be ...

PERTH, Australia – Neuroscience technology company Cogstate Ltd. and Japanese pharmaceutical company Eisai Co. Ltd. signed a deal under which Eisai will have global development rights and exclusive ...

Cogstate Ltd ( ($AU:CGS) ) just unveiled an announcement. Cogstate has disclosed a change in director Kim Wenn’s beneficial interest in the ...

decentralized research and electronic clinical outcome assessment (eCOA) provider, today announced a collaboration with cognitive science leaders Cogstate Limited (ASX:CGS). The partnership combines ...